Sequana Medical NV (SEQUA.BR)
EUR 0.72
(3.43%)
EUR 0.72
(3.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 712.17 Thousand | 922.68 Thousand | 370.5 Thousand | 963.28 Thousand | 970.63 Thousand | 1.02 Million |
| Cost of Revenue | 164.12 Thousand | 204.59 Thousand | 76.66 Thousand | 202.41 Thousand | 197.75 Thousand | 158.05 Thousand |
| Gross Profit | 548.04 Thousand | 718.09 Thousand | 293.83 Thousand | 760.86 Thousand | 772.88 Thousand | 871.11 Thousand |
| Operating Expenses | 30.03 Million | 28.81 Million | 22.9 Million | 18.53 Million | 14.73 Million | 13.94 Million |
| Selling, General and Administrative Expenses | 25.99 Million | 8.92 Million | 7.17 Million | 6.73 Million | 7.1 Million | 8.2 Million |
| Research and Development Expenses | 4.04 Million | 7.7 Million | 6.14 Million | 4.43 Million | 2.52 Million | 934.79 Thousand |
| Other Expenses | - | 19.88 Million | 15.73 Million | 11.79 Million | 7.63 Million | 73.72 Thousand |
| Cost and Expenses | 30.2 Million | 29.01 Million | 22.98 Million | 18.73 Million | 14.93 Million | 14.1 Million |
| Operating Income | -29.49 Million | -28.38 Million | -22.64 Million | -17.87 Million | -14.07 Million | -13.03 Million |
| Interest Expense | 4.28 Million | 879.95 Thousand | 572.5 Thousand | 1.07 Million | 770.58 Thousand | 921.95 Thousand |
| Income Tax Expense | 465.6 Thousand | 386.62 Thousand | 393.27 Thousand | 157.02 Thousand | 135.99 Thousand | 23.55 Thousand |
| Earnings before Tax | -32.09 Million | -30.37 Million | -23.22 Million | -18.94 Million | -14.84 Million | -13.95 Million |
| Net Income | -32.56 Million | -30.76 Million | -23.61 Million | -19.1 Million | -14.97 Million | -13.98 Million |
| Earnings Per Share Basic | -1.22 | -1.35 | -1.30 | -1.25 | -1.22 | -1.02 |
| Earnings Per Share Diluted | -1.22 | -1.35 | -1.30 | -1.25 | -1.22 | -1.02 |
| Weighted Average Shares Outstanding | 26.77 Million | 22.76 Million | 18.21 Million | 15.31 Million | 12.29 Million | 13.65 Million |
| Weighted Average Shares Outstanding (Diluted) | 26.77 Million | 22.76 Million | 18.21 Million | 15.31 Million | 12.29 Million | 13.65 Million |
| Gross Margin | 0.77 | 0.78 | 0.79 | 0.79 | 0.80 | 0.85 |
| EBIT Margin | -40.91 | -30.43 | -60.03 | -18.24 | -14.25 | -12.59 |
| Profit Margin | -45.72 | -33.34 | -63.74 | -19.83 | -15.43 | -13.59 |
| EBITDA | -29.13 Million | -29.19 Million | -22.24 Million | -17.56 Million | -13.82 Million | -13.01 Million |
| Earnings Before Tax Margin | -41.41 | -30.77 | -61.13 | -18.55 | -14.50 | -12.67 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 52.75 Thousand | 52.75 Thousand | 712.17 Thousand | 164 Thousand | 164 Thousand | 384.17 Thousand |
| Cost of Revenue | 13.04 Thousand | 13.04 Thousand | 4.86 Million | 37.82 Thousand | 37.82 Thousand | 2.32 Million |
| Gross Profit | 39.7 Thousand | 39.7 Thousand | -4.15 Million | 126.17 Thousand | 126.17 Thousand | -1.94 Million |
| Operating Expenses | 4.9 Million | 4.9 Million | 25.59 Million | 7.05 Million | 7.54 Million | 13.31 Million |
| Selling, General and Administrative Expenses | 4.41 Million | 4.41 Million | - | 6.08 Million | 6.08 Million | 9.6 Million |
| Research and Development Expenses | 491.19 Thousand | 491.19 Thousand | - | 972.91 Thousand | 972.91 Thousand | 3.71 Million |
| Other Expenses | - | - | -5.27 Million | -1.56 Million | - | - |
| Cost and Expenses | 4.92 Million | 4.92 Million | 30.46 Million | 7.09 Million | 7.58 Million | 15.64 Million |
| Operating Income | -4.86 Million | -4.86 Million | -29.75 Million | -6.93 Million | -7.03 Million | -15.26 Million |
| Interest Expense | - | - | 4.28 Million | 2.17 Million | - | 2.1 Million |
| Income Tax Expense | 72.8 Thousand | 72.8 Thousand | -161.68 Thousand | 105.21 Thousand | 105.21 Thousand | 255.18 Thousand |
| Earnings before Tax | -5.46 Million | -5.46 Million | -32.72 Million | -7.94 Million | -7.94 Million | -16.2 Million |
| Net Income | -5.53 Million | -5.53 Million | -32.56 Million | -8.04 Million | -8.04 Million | -16.46 Million |
| Earnings Per Share Basic | -0.17 | -0.17 | - | -0.29 | -0.29 | -0.65 |
| Earnings Per Share Diluted | -0.17 | -0.17 | - | -0.29 | -0.29 | -0.65 |
| Weighted Average Shares Outstanding | 32.35 Million | 32.35 Million | 26.77 Million | 28.24 Million | 28.24 Million | 25.3 Million |
| Weighted Average Shares Outstanding (Diluted) | 32.35 Million | 32.35 Million | 26.77 Million | 28.24 Million | 28.24 Million | 25.3 Million |
| Gross Margin | 0.75 | 0.75 | -5.83 | 0.77 | 0.77 | -5.06 |
| EBIT Margin | -89.61 | -89.61 | - | -42.27 | -42.27 | -39.35 |
| Profit Margin | -105.02 | -105.02 | -45.72 | -49.08 | -49.08 | -42.86 |
| EBITDA | -4.72 Million | -4.72 Million | - | -6.93 Million | -6.93 Million | -15.11 Million |
| Earnings Before Tax Margin | -92.29 | -92.29 | -41.78 | -42.27 | -42.91 | -39.72 |
MNMD
VEV
SIE
0222
9362
2230